Sale!

UBE3A Gene Angelman syndrome Genetic Test

4,400 د.إ

-21%

The UBE3A Gene Angelman Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the UBE3A gene, which are closely linked to Angelman syndrome. Angelman syndrome is a genetic disorder that primarily affects the nervous system, leading to developmental delays, problems with speech and balance, intellectual disability, and sometimes, seizures. This condition is often caused by the loss of function of the UBE3A gene located on chromosome 15.

DNA Labs UAE utilizes advanced genetic testing techniques to analyze the UBE3A gene for any abnormalities that might indicate the presence of Angelman syndrome. This test is crucial for early diagnosis and intervention, which can significantly improve the quality of life for individuals with this condition. The cost of the UBE3A Gene Angelman Syndrome Genetic Test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the invaluable insights it provides to affected families. Early diagnosis through this test can lead to better management strategies and support for individuals with Angelman syndrome and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

UBE3A Gene Angelman Syndrome Genetic Test

Welcome to DNA Labs UAE, a leading genetic lab specializing in DNA testing and analysis. In this blog post, we will discuss the UBE3A Gene Angelman Syndrome Genetic Test, its components, cost, symptoms, diagnosis, and more.

Test Name: UBE3A Gene Angelman Syndrome Genetic Test

Components: This test analyzes the UBE3A gene, which is responsible for producing a protein called ubiquitin-protein ligase E3A. The test focuses on identifying mutations or deletions in this gene that may be linked to Angelman Syndrome.

Price: The cost of the UBE3A Gene Angelman Syndrome Genetic Test is 4400.0 AED.

Sample Condition: The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery: The test results will be delivered within 3 to 4 weeks.

Method: The UBE3A Gene Angelman Syndrome Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type: This test focuses on neurological disorders, specifically Angelman Syndrome.

Doctor: The test is typically conducted under the supervision of a neurologist.

Test Department: The UBE3A Gene Angelman Syndrome Genetic Test is conducted in our Genetics department.

Pre Test Information:

Prior to conducting the UBE3A Gene Angelman Syndrome Genetic Test, it is important to gather the clinical history of the patient. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected by UBE3A Gene Angelman Syndrome.

Test Details:

The UBE3A gene is crucial for the development and function of the brain. It produces a protein called ubiquitin-protein ligase E3A. However, mutations or deletions in this gene can lead to Angelman Syndrome, a rare genetic disorder characterized by developmental delay, intellectual disability, speech impairment, and seizures.

NGS (Next-Generation Sequencing) genetic testing is a powerful diagnostic tool used to identify changes or mutations in the UBE3A gene that may be responsible for Angelman Syndrome. This advanced DNA sequencing technology allows for the simultaneous analysis of multiple genes, providing a comprehensive and accurate assessment of a patient’s genetic makeup.

By conducting the UBE3A Gene Angelman Syndrome Genetic Test, doctors and genetic counselors can diagnose Angelman Syndrome early, enabling earlier interventions and better outcomes for patients. Additionally, this test can identify carriers of the genetic mutation who may be at risk of passing it on to their children.

At DNA Labs UAE, we are committed to providing reliable and accurate genetic testing services. If you suspect Angelman Syndrome or have a family history of the disorder, consider getting the UBE3A Gene Angelman Syndrome Genetic Test for a comprehensive understanding of your genetic profile.

Test Name UBE3A Gene Angelman syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for UBE3A Gene Angelman syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with UBE3A Gene Angelman syndrome
Test Details

The UBE3A gene is responsible for producing a protein called ubiquitin-protein ligase E3A, which plays a crucial role in the brain’s development and function. Mutations or deletions in this gene can lead to Angelman syndrome, a rare genetic disorder characterized by developmental delay, intellectual disability, speech impairment, and seizures.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify changes or mutations in the UBE3A gene that may be responsible for Angelman syndrome. This type of testing uses advanced DNA sequencing technology to analyze multiple genes simultaneously, providing a more comprehensive and accurate assessment of a patient’s genetic makeup.

NGS genetic testing can help doctors and genetic counselors diagnose Angelman syndrome early, which can lead to earlier interventions and better outcomes for patients. It can also help identify carriers of the genetic mutation who may be at risk of passing it on to their children.